Covid Report: Small Biotech Doubles On Plans To Test A Coronavirus Drug

Covid Report: Small Biotech Doubles On Plans To Test A Coronavirus Drug

Shares of FSD Pharma doubled Wednesday after the small-cap biotech company announced plans to study a potential coronavirus treatment. The drug is called ultramicronized PEA.